Items related to biologics will be added to the top of the list as they are posted on the site.
11/17/2021
October 1, 2021 Clinical Review and Evaluation - TECARTUS
11/17/2021
Pharmacology/Toxicology Review - TECARTUS
11/17/2021
Statistical Review - TECARTUS
11/17/2021
Clinical Review - CUTAQUIG
11/17/2021
Statistical Review - CUTAQUIG
11/17/2021
CBER-Regulated Products: Current Shortages
11/17/2021
2021 Biological License Application Approvals
11/17/2021
2021 Biological Device Application Approvals
11/17/2021
2021 Biological License Application Supplement Noteworthy Approvals
11/16/2021
eSubmitter Application History
11/12/2021
CBER-Regulated Products: Resolved Shortages
11/10/2021
November 5, 2021 Untitled Letter - NYC Regenerative Medicine, Inc. dba Colts Neck Stem Cells and Regenerative Medicine
11/10/2021
November 8, 2021 Summary Basis for Regulatory Action - Comirnaty
11/8/2021
eSubmitter Application History
11/8/2021
CBER Vacancy: Principal Investigator - Pathogen Reduction of Whole Blood: Hematology and Coagulation Biology
11/8/2021
CBER Vacancy: Principal Investigator – Pathogen Reduction of Whole Blood: Microbiology and Infectious Diseases
11/5/2021
CBER Vacancy: Staff Fellow - Biologist/Microbiologist
11/4/2021
Regenerative Medicine 101 Webinar: Information for Patients, Caregivers & Advocates
11/3/2021
Influenza Vaccine for the 2021-2022 Season
11/3/2021
Manufacture of Blood Components Using a Pathogen Reduction Device in Blood Establishments: Questions and Answers; Guidance for Industry
11/2/2021
October 27, 2021 Approval Letter - KOVALTRY
11/2/2021
Complete List of Licensed Products and Establishments
11/2/2021
Complete List of Substantially Equivalent 510(k) Device Applications
11/2/2021
Complete List of Currently Approved Premarket Approvals (PMAs)
11/2/2021
Complete List of Currently Approved NDA and ANDA Application Submissions
11/2/2021
BK210621 - rControl RBC and PLT
11/1/2021
October 29, 2021 Approval Letter - AUDENZ
10/29/2021
October 8, 2021 Summary Basis for Regulatory Action - RETHYMIC
10/29/2021
October 27, 2021 Untitled Letter - Riverside Biologics
10/28/2021
October 27, 2021 Approval Letter - PNEUMOVAX 23
10/28/2021
Exceptions and Alternative Procedures Approved Under 21 CFR 640.120
10/28/2021
October 27, 2021 Approval Letter - MenQuadfi
10/28/2021
Influenza Vaccine for the 2021-2022 Season
10/27/2021
October 22, 2021 Approval Letter - CUTAQUIG
10/26/2021
October 22, 2021 Approval Letter - ZOLGENSMA
10/25/2021
2021 Biological License Application Approvals
10/25/2021
2021 Biological Device Application Approvals
10/22/2021
Clinical Review (125408/351) - Flucelvax Quadrivalent
10/22/2021
Statistical Review (125408/351) - Flucelvax Quadrivalent
10/22/2021
PREA Non-Compliance Letters
10/21/2021
Staff Fellow – Bioinformatics Reviewer
10/21/2021
Influenza Vaccine for the 2021-2022 Season
10/19/2021
PREA Non-Compliance Letters
Content current as of:
11/17/2021